Vylor Inc.

NYSE:VYLR

Agricultural Inputs

Basic Materials
$69.82 -1.44%

-$1.07 today

Market cap
$46.58B
Beta
0.58
52W Low $65.00High $77.39

Volume 4.60M

Average 8.71M

Financial health

Vylor Inc. financial health

Start with the overall verdict and the rule-based risk checks for VYLR, then work through liquidity, debt, balance-sheet quality, and claims on cash.

Financial health snapshot

Resilient

Debt service and balance sheet cushion look healthy, even if some working-capital ratios deserve context.

Cash and investments cover debt Healthy short-term liquidity Moderate leverage

Cash & Investments

$4.08B

Debt Cushion

$444.00M

Current Ratio

1.6x

Interest Coverage

N/A

Risk checks

1 of 10 flagged

  • Tangible equity base

    74.6%

    Passes when: Goodwill and intangibles are below 50% of equity

  • Positive equity

    Positive

    Passes when: Shareholders' equity is above zero

  • Interest covered

    339.6×

    Passes when: Operating income is at least 1.5× interest expense

  • Short-term liquidity

    1.6×

    Passes when: Current assets are at least 1× current liabilities

  • Near-term debt covered

    21.5×

    Passes when: Cash and short-term investments cover debt due within 12 months

  • Manageable net debt

    Net cash

    Passes when: Net debt is below 3× EBITDA

  • Debt repayable from cash flow

    1.7 yrs

    Passes when: Free cash flow could repay all debt within 5 years

  • Stable Altman Z-Score

    4.19 → 3.77

    Passes when: Z-Score is not falling while below the 2.99 safe zone

  • Contained stock compensation

    0.0%

    Passes when: Stock-based compensation is below 20% of operating cash flow

  • Limited dilution

    +0.0%/yr

    Passes when: Diluted share count grows less than 2% a year

Financial strength scores

How strong are the fundamentals over time?

Piotroski tests profitability, balance-sheet direction, and efficiency; Altman estimates bankruptcy risk. Compare the current scores with their fiscal-year history.

Financial strength scores

Piotroski F-Score and Altman Z-Score from the latest reported financials

No financial scores available.

Score history

Piotroski F-Score and Altman Z-Score recalculated from each fiscal year's statements and year-end market value.

Piotroski: 8–9 strong, 4–7 average, 0–3 weak. Altman: above 2.99 safe, 1.81–2.99 grey, below 1.81 distress. Our calculation can differ slightly from the provider's current scores above.

Liquidity

Can it meet short-term obligations?

Check whether cash and current assets cover what falls due within a year without depending on fresh financing.

Cash & Equivalents

$3.93B

Q3 2026

1Y +66.3%

Quick Ratio

1.1x

Q3 2026

Current Ratio

1.6x

Q3 2026

Cash Ratio

0.3x

Q3 2026

Working capital

How quickly does cash come back?

Receivable, inventory, and payable days show how much cash the operating cycle ties up and whether that is changing.

Working capital and cash conversion

Annual days measures from year-end receivables, inventory, and payables against revenue and cost of revenue.

Working capital (Q3 2026)

$6.44B

Current assets − current liabilities

Days sales outstanding

67 days

-2 days vs prior year

Days inventory outstanding

257 days

+20 days vs prior year

Days payables outstanding

165 days

+18 days vs prior year

Cash conversion cycle

159 days

+1 days vs prior year

Leverage

How much debt risk sits on the balance sheet?

Review total borrowings, debt relative to equity and assets, and whether operating profit covers interest costs.

Total Debt

$3.64B

Q3 2026

1Y -25.3%

Debt/Equity

0.1x

Q3 2026

Debt/Assets

0.1x

Q3 2026

Interest Coverage

—

Q3 2026

Debt service

Can cash flow carry the debt?

Measure debt against EBITDA and free cash flow, see how much is due within 12 months, and follow debt and cash over time.

Debt service capacity

Can operating cash flow carry the debt, and how much is due soon?

Net debt

Net cash $297M

Total debt − cash − short-term investments

Net debt / EBITDA

Net cash

Above 3× is elevated

Free cash flow / debt

59.3%

Share of debt one year of FCF could repay

Years to repay debt

1.7 yrs

Total debt ÷ free cash flow

Operating cash flow / current liabilities

0.2×

Above 1× funds a year of obligations

Interest coverage

339.6×

Operating income ÷ interest expense

Debt maturity

Cash and short-term investments cover short-term debt 21.5×

Due within 12 months$183MDue later$3.46B

Balance sheet as of Q3 2026; cash flows FY 2025.

Debt and cash over time

Fiscal-year-end borrowings against liquid assets; net debt below zero means net cash.

Balance sheet cushion

How much room is there if conditions weaken?

Extra cash and investments, and the balance of assets against liabilities, give the company room when trading gets harder.

Long-Term Investments

$147.00M

Q3 2026

1Y +1.4%

Assets

$43.03B

Q3 2026

1Y +3.3%

Liabilities

$18.29B

Q3 2026

1Y +12.7%

Balance sheet quality

Who funds the assets, and how tangible is the equity?

Split the claims on assets between suppliers, lenders, customers, and shareholders, and see how much equity rests on goodwill and intangibles.

Balance sheet quality

Who funds the assets, and how much of the equity is tangible (Q3 2026).

Claims on $43.03B of assets

  • Payables10.3%
  • Short-term debt0.4%
  • Long-term debt8.0%
  • Deferred revenue1.0%
  • Other liabilities22.7%
  • Equity57.5%

Goodwill + intangibles

$18.26B

42.4% of total assets

Share of equity

74.6%

Above 50% leaves little tangible backing

Tangible equity

$6.23B

Equity left after writing off goodwill and intangibles

Deferred revenue

$440M

Customer prepayments: a liability settled by delivering service, not cash

Shareholder claims

What do shareholders take out of the cash?

Dilution, stock-based pay, dividends, and buybacks all draw on cash flow; check whether free cash flow funds them.

Shareholder claims on cash

Dilution, stock-based pay, and whether free cash flow funds what is returned to shareholders.

Diluted shares, yearly change

+0.0%

FY2024–FY2025 compound rate

Stock-based compensation

$0

0.0% of operating cash flow

Dividends paid

None

FY 2025

Dividend / free cash flow

—

Above 100% means dividends exceed free cash flow

Buybacks

None

FY 2025

Weighted diluted shares outstanding

Competitor health

How does Vylor Inc. compare with peers?

Compare leverage, interest coverage, and liquidity ratios with similar companies.

Competitor Health

Peer financial health comparison

CompanyMarket CapD/ED/AssetsND/EBITDAInt. Cov.QuickCurrentCash

EIDP, Inc. USD 4.50 Cum Pfd Registered Shs

CTA-PB:NYSE

$47.05B0.110.06Net cash14.550.961.430.37

Nutrien Ltd.

NTR:NYSE

$33.78B0.510.251.995.310.701.340.06

EIDP, Inc.

CTA-PA:NYSE

$29.77B0.110.06Net cash14.550.961.430.37

The Mosaic Company

MOS:NYSE

$6.97B0.440.222.024.820.471.320.07

Corteva, Inc.

CTVA:NYSE

$6.29B0.110.06Net cash14.550.961.430.37

ICL Group Ltd

ICL:NYSE

$5.83B0.460.221.822.360.711.330.09

Questions

Financial health questions

Common questions about VYLR's balance sheet, answered from the reported figures.

Is VYLR's balance sheet healthy?

Vylor Inc. (VYLR) has a current ratio of 1.56, a quick read on short-term liquidity.

How leveraged is VYLR?

Debt to equity is 0.15, which helps judge how much financing risk sits on the balance sheet.